{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:16:47Z","timestamp":1794543407363,"version":"4.9.1"},"reference-count":58,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["COPD: Journal of Chronic Obstructive Pulmonary Disease"],"published-print":{"date-parts":[[2017,9,3]]},"DOI":"10.1080\/15412555.2017.1347918","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T11:37:10Z","timestamp":1501241830000},"page":"552-563","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":86,"title":["Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4895-9707","authenticated-orcid":false,"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-5040","authenticated-orcid":false,"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino","family":"Calzetta","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola A.","family":"Hanania","sequence":"additional","affiliation":[{"name":",","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-9235","authenticated-orcid":false,"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[{"name":",","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis Management and Prevention of COPD \u2013 2017. Available at: http:\/\/goldcopd.org\/gold-2017-global-strategy-diagnosis-management-prevention-copd\/ (accessed April 6 2017)."},{"key":"e_1_3_5_3_1","first-page":"CD001287","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole P","year":"2015","unstructured":"Poole P, Chong J, Cates CJ. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015:CD001287.","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01170-2015"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2009.10.002"},{"key":"e_1_3_5_6_1","article-title":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews (Internet) - Centre for Reviews and Dissemination (UK)","author":"DARE","unstructured":"DARE. Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews (Internet) - Centre for Reviews and Dissemination (UK). The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data. Available at: https:\/\/www.ncbi.nlm.nih.gov\/pubmedhealth\/PMH0029749\/ (accessed January 22, 2017).","journal-title":"The therapeutic efficacy of erdosteine in the treatment of chronic obstructive bronchitis: a meta-analysis of individual patient data"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2013.039"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3767"},{"key":"e_1_3_5_9_1","unstructured":"NICE. National Clinical Guideline Centre. Chronic obstructive pulmonary disease in over 16 s: diagnosis and management. Available at: https:\/\/www.nice.org.uk\/guidance\/CG101 (accessed January 22 2017)."},{"key":"e_1_3_5_10_1","first-page":"e123","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement","volume":"3","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009; 3:e123\u2013e130.","journal-title":"Open Med."},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008730"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00099306"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.124164"},{"key":"e_1_3_5_15_1","unstructured":"GOLD. Global Strategy for the Diagnosis Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http:\/\/goldcopd.org (accessed June 12 2017)."},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1676"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2016.07.009"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.02.646"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00242-0"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-9-80"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/28.1.1"},{"key":"e_1_3_5_23_1","article-title":"Impact of a biomarker-based strategy on oncology drug development: a meta-analysis of clinical trials leading to FDA approval","volume":"107","author":"Jardim DL","year":"2015","unstructured":"Jardim DL, Schwaederle M, Wei C, Lee JJ, Hong DS, Eggermont AM, et\u00a0al. Impact of a biomarker-based strategy on oncology drug development: a meta-analysis of clinical trials leading to FDA approval. J Natl Cancer Inst. 2015; 107: djv253.","journal-title":"J Natl Cancer Inst."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v2.i4.27"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"e_1_3_5_26_1","unstructured":"Higgins JPT Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. (updated March 2011). Available from www.cochrane-handbook.org. The Cochrane Collaboration. 2011."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-010-0087-7"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.00002215"},{"key":"e_1_3_5_29_1","first-page":"351","article-title":"Effect of high\/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Shen Y","year":"2014","unstructured":"Shen Y, Cai W, Lei S, Zhang Z. Effect of high\/low dose N-acetylcysteine on chronic obstructive pulmonary disease: a systematic review and meta-analysis. COPD. 2014; 11:351\u2013358.","journal-title":"COPD."},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2017.06.002"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-4-17"},{"key":"e_1_3_5_32_1","unstructured":"DeCoster J. Meta-analysis notes. http:\/\/www.stat-help.com\/meta.pdf (accessed June 14 2017. 2004)."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12215"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0043-2016"},{"key":"e_1_3_5_35_1","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","author":"Lu G","year":"2012","unstructured":"Lu G, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Statist Assoc. 2012.","journal-title":"J Am Statist Assoc."},{"key":"e_1_3_5_36_1","doi-asserted-by":"crossref","unstructured":"Spiegelhalter DJ Abrams KR Myles JP. Bayesian approaches to clinical trials and health-care evaluation: John Wiley & Sons. 2004.","DOI":"10.1002\/0470092602"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1054"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1167"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12455847"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098616667304"},{"key":"e_1_3_5_41_1","first-page":"1","article-title":"Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis","author":"Rogliani P","year":"2016","unstructured":"Rogliani P, Calzetta L, Cazzola M, Matera MG. Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis. Expert Opin Drug Saf. 2016:1\u201314.","journal-title":"Expert Opin Drug Saf."},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v049.i05"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70286-8"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2357"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.11.003"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66456-2"},{"key":"e_1_3_5_47_1","first-page":"12","article-title":"Effect of oral N-acetylcysteine in COPD-A randomised controlled trial","volume":"14","author":"Bachh AA","year":"2007","unstructured":"Bachh AA, Shah NN, Bhargava R, Ahmed Z, Pandey DK, Dar KA, et\u00a0al. Effect of oral N-acetylcysteine in COPD-A randomised controlled trial. JK Pract. 2007; 14:12\u201316.","journal-title":"JK Pract."},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000029447"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60869-7"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01373.x"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.00592_9.x"},{"key":"e_1_3_5_52_1","first-page":"143","article-title":"The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE study","volume":"30","author":"Moretti M","year":"2004","unstructured":"Moretti M, Bottrighi P, Dallari R, Da Porto R, Dolcetti A, Grandi P, et\u00a0al. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE study. Drugs Exp Clin Res. 2004; 30:143\u2013152.","journal-title":"Drugs Exp Clin Res."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2003.08.004"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060410"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1863PP"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.733463"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2784"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-016-0500-y"}],"container-title":["COPD: Journal of Chronic Obstructive Pulmonary Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15412555.2017.1347918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:12:52Z","timestamp":1770927172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15412555.2017.1347918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9,3]]}},"alternative-id":["10.1080\/15412555.2017.1347918"],"URL":"https:\/\/doi.org\/10.1080\/15412555.2017.1347918","relation":{},"ISSN":["1541-2555","1541-2563"],"issn-type":[{"value":"1541-2555","type":"print"},{"value":"1541-2563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-07-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}